Skip to content
10-Q

Quarterly Report

BioTelemetry, Inc.

0001574774-20-000047

← back to feed
Filed
May 6, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Apr 30, 2020 34.14M sh
Shares Diluted Q1 2020 · Mar 31, 2020 36.59M sh
Shares Diluted Q1 2020 · Mar 31, 2019 36.41M sh
Capex Q1 2020 · Mar 31, 2020 $6.98M
Capex Q1 2020 · Mar 31, 2019 $5.33M
Operating Cash Flow Q1 2020 · Mar 31, 2020 $12.7M
Operating Cash Flow Q1 2020 · Mar 31, 2019 $17.54M
Long Term Debt Q1 2020 · Mar 31, 2020 $227.43M
Long Term Debt Q1 2020 · Dec 31, 2019 $190.82M
Short Term Debt Q1 2020 · Mar 31, 2020 $0
Short Term Debt Q1 2020 · Dec 31, 2019 $3.84M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $106.85M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $68.61M
Cash And Equivalents Q1 2020 · Mar 31, 2019 $45.49M
Cash And Equivalents Q1 2020 · Dec 31, 2018 $80.89M
Stockholders Equity Q1 2020 · Mar 31, 2020 $377M
Stockholders Equity Q1 2020 · Dec 31, 2019 $366.92M
Current Liabilities Q1 2020 · Mar 31, 2020 $49.09M
Current Liabilities Q1 2020 · Dec 31, 2019 $55.75M
Total Liabilities Q1 2020 · Mar 31, 2020 $363.43M
Total Liabilities Q1 2020 · Dec 31, 2019 $318.8M
Current Assets Q1 2020 · Mar 31, 2020 $213.07M
Current Assets Q1 2020 · Dec 31, 2019 $168.33M
Total Assets Q1 2020 · Mar 31, 2020 $740.43M
Total Assets Q1 2020 · Dec 31, 2019 $685.72M
Eps Diluted Q1 2020 · Mar 31, 2020 $0.19
Eps Diluted Q1 2020 · Mar 31, 2019 $0.32
Eps Basic Q1 2020 · Mar 31, 2020 $0.21
Eps Basic Q1 2020 · Mar 31, 2019 $0.35
Sga Expense Q1 2020 · Mar 31, 2020 $31.88M
Sga Expense Q1 2020 · Mar 31, 2019 $27.61M
Rd Expense Q1 2020 · Mar 31, 2020 $3.57M
Rd Expense Q1 2020 · Mar 31, 2019 $3.33M
Operating Income Q1 2020 · Mar 31, 2020 $13.51M
Operating Income Q1 2020 · Mar 31, 2019 $13.18M
Gross Profit Q1 2020 · Mar 31, 2020 $70.51M
Gross Profit Q1 2020 · Mar 31, 2019 $64.78M
Cost Of Revenue Q1 2020 · Mar 31, 2020 $42.52M
Cost Of Revenue Q1 2020 · Mar 31, 2019 $39.2M